NOVARTIS, formerly Chiron (Liverpool factory formerly owned by Medeva then Evans Vaccines)
[2011 Aug] Were children vaccinated with MeNZB more likely to die as a result of being vaccinated?
[2005 pdf] The Meningococcal Gold Rush Pt 1 By Barbara Sumner Burstyn & Ron Law
EXECUTIVE SUMMARY: New Zealand's meningococcal disease story, as unravelled
through analysis of previously secret documents obtained under the Official
Information Act, reveals that the New Zealand government, media and public have
been mislead and manipulated by officials, advisors and scientists alike.
As a result of this manipulation, the government has
committed an unprecedented 200 million taxpayer dollars to a mass vaccination
experiment of 1.15 million New Zealand children with an untested and
experimental vaccine. Despite being reassured by a bevy of pro-vaccine and
vaccine manufacturer sponsored experts and none-less than the Minister of Health
herself that the MeNZB(tm) vaccine is thoroughly tested and proven to be safe
and effective, we reveal that Chiron's MeNZB(tm) vaccine was never used in the
trails used to approve its license. We reveal that despite assurances, there is
no evidence that the MeNZB(tm) vaccine will actually work as promised.
We believe that the magnitude of policy, regulatory and
scientific misconduct is such that not only should vaccination with this vaccine
be halted forthwith, but that the meningococcal vaccination program should be
independently audited and the circumstances surrounding the development and
implementation of the program subjected to a full Royal Commission of Inquiry.
[2005 pdf] The Meningococcal Gold Rush Pt 2 By Barbara Sumner Burstyn & Ron Law the Ministry of Health’s critique of The Meningococcal Gold Rush and Ron Law and Barbara Sumner Burstyn’s response.
Menjugate ® (Chiron) Injection, powder for
reconstitution, capsular polysaccharide antigen of Neisseria meningitidis group C
(conjugated to
Corynebacterium diphtheriae protein), adsorbed onto aluminium hydroxide, single-dose and
10-dose vials
The Liverpool plant concerned was formerly owned by Powderject, run by the Labour party donor Paul Drayson, once at the heart of a dispute over a contract for smallpox vaccines, but that company was bought by Chiron last year [2003].
[Media Nov 2006] Mersey plant in £20m US deal for bird flu vaccine NOVARTIS'S factory in Liverpool is to supply 800,000 extra doses of its H5N1 bird flu vaccine to the US government in a deal worth more than £20m.[Oct 2006] Novartis/Chiron Liverpool, England] 500,000 Flu-Shot Doses Recalled
Meningitis C vaccine damage (media stories UK)
Meningitis Vaccine under Scrutiny in UK (2001)
Miracle or Murder? The Hepatitis B Vaccine Controversy
[Media October 7, 2004
Flu vaccine] A Biotech Company's Aggressive Move Backfires
[Media Oct 2004] Flu vaccine maker's shipments suspended,
raising fears of flu shot shortage at start of season
[Media Oct 2004] Flu Vaccine Shortage Prompts U.S. Probe